The global synthetic biology market is expected to grow from USD 9.5 billion in 2021 to USD 30.7 billion in 2026, with a compound annual growth rate of 26.5%


New York, May 31, 2021 (GLOBE NEWSWIRE) – announced the release of the report “Synthetic Biology Market by Tools, Technologies, Applications and Regions-Global Forecast to 2026”-
However, the increasingly serious biosafety, biosecurity and ethical issues related to synthetic biology may hinder the growth of this market.

It is expected that during the forecast period, oligonucleotides and synthetic DNA fragments will grow at the highest rate.
On the basis of tools, the synthetic biology market is roughly divided into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms and heterogeneous nucleic acids. In 2020, the oligonucleotide and synthetic DNA parts are expected to register the highest compound annual growth rate during the forecast period.

This can be attributed to factors such as the growing demand for synthetic DNA, synthetic RNA and synthetic genes, which are widely used in pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes .

During the forecast period, the genome engineering segment is expected to grow at the highest compound annual growth rate.
On the basis of technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology.
Due to the increasing use of engineering technology to manipulate complex genomes, the continuous development of treatments for cancer and other diseases, and the continuous advancement of CRISPR toolboxes and technologies, the genome engineering part is expected to record the highest compound year during the forecast period growth rate. DNA synthesis technology.

During the forecast period, the medical application field is expected to grow at the highest compound annual growth rate.
Based on applications, the synthetic biology market is segmented into medical applications, industrial applications, food and agriculture, and environmental applications. The medical application segment is expected to have the highest compound annual growth rate during the forecast period.

Factors such as extensive research on new and better treatments, and the availability of large amounts of private and public funds for the discovery of new therapies, are the main driving forces for the growth of medical applications.

The Asia-Pacific region is expected to achieve the highest growth during the forecast period.
The synthetic biology market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2020, North America will account for the largest share of the synthetic biology market.

However, due to the growth in the number of pharmaceutical and biopharmaceutical companies, the increasing number of healthcare and life science facilities, and the increasing regulatory compliance requirements of pharmaceutical and biopharmaceutical companies, the Asia-Pacific region is expected to experience the highest growth during the forecast period. More and more international alliances, large amounts of funds for synthetic biology research, and strong government support. In addition, the Asia-Pacific market is receiving increasing attention due to its low-cost manufacturing advantages, which also provides growth opportunities for manufacturers.

The main interviews conducted for this report can be divided into the following categories:
• By respondents: supply side-70%, demand side-30%
• By designation (supply side): managers-45%, CXO and directors-30%, executives-25%
• By region: North America -40%, Europe -25%, Asia Pacific -20%, Latin America -10%, Middle East and Africa -5%

List of companies introduced in the report:
• Thermo Fisher Scientific Inc. (United States)
• Merck KGaA (Germany)
• Agilent Technologies (United States)
• Novozymes A/S (Denmark)
• Ginkgo Bioworks (United States)
• Amyris, Inc. (United States)
• Precigen, Inc. (United States)
• GenScript Biotechnology Company (China)
• Twist Bioscience (United States)
• Synthetic Genomics, Inc. (United States)
• Codexis, Inc. (United States)
• Synthego Corporation (United States)
• Creative Enzyme (United States)
• Eurofins Scientific (Luxembourg)
• Cyrus Biotechnology Inc. (United States)
• Sturm (United States)
• TeselaGen (United States)
• Arzeda (United States)
• Integrated DNA Technologies, Inc. (United States)
• New England Biological Laboratory (United States).

area of ​​research:
This report details the synthetic biology market. It aims to estimate the market size and future growth potential of different fields such as tools, technologies, applications and regions.

The report also includes in-depth competitive analysis of major market participants, as well as their company profiles, recent developments and key market strategies.

The main benefits of buying a report:
This report will help market leaders/new entrants by providing the closest revenue figures for the overall synthetic biology market and its sub-segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and formulate appropriate listing strategies.

The report will enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, constraints, opportunities and challenges.
Read the full report:

on Report linker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all the market research you need-in one place instantly.


US: (339)-368-6001
Intl: +1 339-368-6001

Main logo


Source link

Recommended For You

About the Author: News Center